Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

SHE:300841 Revenue

Chengdu Kanghua Biological Products had revenue of 172.45M CNY in the quarter ending March 31, 2026, with 25.02% growth. This brings the company's revenue in the last twelve months to 1.20B, down -4.68% year-over-year. In the year 2025, Chengdu Kanghua Biological Products had annual revenue of 1.17B, down -18.64%.

• Revenue (ttm): 1.20B
• Revenue Growth: -4.68%
• P/S Ratio: 6.39
• Revenue / Employee: 2.18M
• Employees: 550
• Market Cap: 7.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	-266.88M	-18.64%
Dec 31, 2024	1.43B	-145.52M	-9.23%
Dec 31, 2023	1.58B	130.67M	9.03%
Jan 1, 2023	1.45B	154.28M	11.94%
Jan 1, 2022	1.29B	253.81M	24.44%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error